Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The classical complement pathway: mechanism of activation of the first component by antigen-antibody complexes.

× No keyword cloud information.

11 in total

Review 1. Autoantibodies against C1q: view on clinical relevance and pathogenic role.

Authors: C E Siegert; M D Kazatchkine; A Sjöholm; R Würzner; M Loos; M R Daha
Journal: Clin Exp Immunol Date: 1999-04 Impact factor: 4.330

2. Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).

Authors: R H van den Berg; C E Siegert; M C Faber-Krol; T W Huizinga; L A van Es; M R Daha
Journal: Clin Exp Immunol Date: 1998-02 Impact factor: 4.330

3. The collagen-like component of the complement system, C1q, is recognized by 7 S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritis.

Authors: P K Trinder; M J Maeurer; D Brackertz; M Loos
Journal: Immunology Date: 1996-03 Impact factor: 7.397

Review 4. The role of complement in immune clearance of blood cells.

Authors: U E Nydegger; M D Kazatchkine
Journal: Springer Semin Immunopathol Date: 1983

Review 5. The role of complement in the induction and regulation of immune responses.

Authors: T G Egwang; A D Befus
Journal: Immunology Date: 1984-02 Impact factor: 7.397

6. [Autoantibodies against the complement component C1q in systemic lupus erythematosus].

Authors: U Antes; H P Heinz; K Hartung; M Loos
Journal: Klin Wochenschr Date: 1990-11-09

7. C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids.

Authors: U Antes; H P Heinz; D Schultz; D Brackertz; M Loos
Journal: Rheumatol Int Date: 1991 Impact factor: 2.631

8. Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A.

Authors: S W Vukajlovich
Journal: Infect Immun Date: 1986-09 Impact factor: 3.441

Review 9. The first component of human complement (C1): activation and control.

Authors: R J Ziccardi
Journal: Springer Semin Immunopathol Date: 1983

10. Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4.

Authors: B Aubert; S Chesne; G J Arlaud; M G Colomb
Journal: Biochem J Date: 1985-12-01 Impact factor: 3.857